Mylan, part of Viatris, is focused on healthcare solutions.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 1 Services tracked
Competitors - Brand Intelligence

About Mylan

Mylan is a company. It operates as a Direct-to-Consumer (D2C). Mylan has completed 8 acquisitions, including Acton Pharmaceuticals, Alaven Pharmaceutical and Geritol. Mylan offers products and services including Quality Medicines.

  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
  • Investments & Acquisitions
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Mylan

Mylan offers a comprehensive portfolio of products and services, including Quality Medicines.

Product name locked
Category locked
Primary

Medicines are provided to improve patient health globally.

People of Mylan

Headcount 1000-5000
Employee Profiles 24
Board Members and Advisors 3
Employee Profiles
People
Paul Campbell
Chief Accounting Officer & Corporate Controller
People
Scott A. Smith
CEO
People
Anil Amin
Chief Business Development Officer
People
David Bayles
Chief Compliance Officer

Unlock access to complete

Board Members and Advisors
people
Elisha W. Finney
Director
people
Robert J. Coury
Executive Chairman
people
Leo Groothuis
Director

Unlock access to complete

Funding Insights of Mylan

Premium access

Detailed funding history for Mylan

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Mylan

Mylan has strategically engaged in corporate development activities, having acquired 8 companies. Notable acquisitions include Acton Pharmaceuticals, Alaven Pharmaceutical and Geritol.

Investments
Premium access

Investment portfolio details for Mylan

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Acquisitions
Company Name Description Domain Location Founded Year Amount
Iron deficiency drugs are manufactured by Palafer for medical applications.
Locked Locked 2017 Locked
Generic drugs for respiratory disorders are manufactured and commercialized.
Locked Locked 2008 Locked
Supplements for managing sleep quality are provided by MidNite.
Locked Locked 2004 Locked
Premium access

Complete acquisition details for Mylan

Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.

  • Transaction dates
  • Acquired stakes
  • Disclosed values
  • Domains and locations

Verified entity values are shown only after access is granted.

Financial Statements - Mylan

Premium access

Detailed financials for Mylan

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Mylan Comparisons

Mylan Primary company
Description
Mylan, part of Viatris, is focused on healthcare solutions.
Location
-
Founded Year
-
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Mylan

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Mylan

Premium access

Detailed competitors of Mylan

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Mylan

Premium access

Complete news archive for Mylan

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mylan

Mylan, now integrated into Viatris, is dedicated to providing access to quality medicines. The company operates in the global healthcare sector, aiming to empower individuals to live healthier lives at every stage. Solutions are developed to ensure patients receive necessary medications when and where needed.

Mylan offers Quality Medicines.

Mylan has made 8 acquisitions, including Acton Pharmaceuticals, Alaven Pharmaceutical, and Geritol.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available